|
US7053041B1
(en)
*
|
1996-05-31 |
2006-05-30 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
|
|
AU726793B2
(en)
*
|
1995-08-14 |
2000-11-23 |
Scripps Research Institute, The |
Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
|
|
US20040063790A1
(en)
*
|
1996-05-31 |
2004-04-01 |
The Scripps Research Institute |
Methods for inhibition of angiogenesis
|
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
|
WO2001025313A1
(en)
*
|
1999-10-06 |
2001-04-12 |
Kaneka Corporation |
Process for producing polyimide resin
|
|
ATE350660T1
(de)
*
|
2001-02-21 |
2007-01-15 |
Eisai Co Ltd |
Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression
|
|
US7019108B2
(en)
*
|
2001-06-01 |
2006-03-28 |
University Of Southern California |
Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2
|
|
CN1536998A
(zh)
*
|
2001-08-01 |
2004-10-13 |
Ĭ��ר������˾ |
用于治疗眼病的整联蛋白抑制剂
|
|
US7301006B2
(en)
*
|
2002-07-16 |
2007-11-27 |
Wisconsin Alumni Research Foundation |
Methods and materials for the synthesis of modified peptides
|
|
FR2856598B1
(fr)
*
|
2003-06-25 |
2005-10-28 |
Inst Nat Sante Rech Med |
Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
|
|
EP1730196B1
(en)
|
2004-03-12 |
2010-12-22 |
Vasgene Therapeutics, Inc. |
Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
|
|
RU2361614C2
(ru)
*
|
2004-03-24 |
2009-07-20 |
ПиДиЭл БАЙОФАРМА, ИНК. |
ПРИМЕНЕНИЕ АНТИТЕЛ ПРОТИВ α5β1 ДЛЯ ИНГИБИРОВАНИЯ ПРОЛИФЕРАЦИИ РАКОВЫХ КЛЕТОК
|
|
BRPI0509420A
(pt)
*
|
2004-04-14 |
2007-09-04 |
Genentech Inc |
método de redução ou inibição da angiogênese e método de aumento da eficácia de tratamento com agente antiangiogênico
|
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
|
EP1799713B1
(en)
|
2004-09-23 |
2014-11-05 |
VasGene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
|
EP2261243A3
(en)
*
|
2005-01-03 |
2011-08-10 |
F. Hoffmann-La Roche AG |
Hemopexin-like structure as polypeptide-scaffold
|
|
WO2006091729A2
(en)
*
|
2005-02-24 |
2006-08-31 |
The Scripps Research Institute |
Revascularization of ischemic retinal tissue and screening method therefor
|
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
US20060286148A1
(en)
*
|
2005-05-18 |
2006-12-21 |
Ppd, Inc. |
Method of forming implants
|
|
CA2619654A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Cell Matrix |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
EP1934867A2
(en)
*
|
2005-08-31 |
2008-06-25 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
JP2009513949A
(ja)
*
|
2005-09-20 |
2009-04-02 |
エンブレクス，インコーポレイテッド |
鳥卵の胚盤葉の位置を迅速かつ正確に特定する方法
|
|
KR20130137716A
(ko)
*
|
2005-11-04 |
2013-12-17 |
제넨테크, 인크. |
안질환 치료를 위한 보체 경로 억제제의 용도
|
|
KR101459159B1
(ko)
|
2006-01-12 |
2014-11-12 |
알렉시온 파마슈티칼스, 인코포레이티드 |
Ｏｘ-2/ｃｄ200에 대한 항체 및 이들의 용도
|
|
AU2007213920B2
(en)
*
|
2006-02-09 |
2013-08-29 |
Amgen Research (Munich) Gmbh |
Treatment of metastatic breast cancer
|
|
US20090298093A1
(en)
*
|
2006-04-27 |
2009-12-03 |
Roberto Polakiewicz |
Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways
|
|
EP1862541A1
(en)
*
|
2006-06-01 |
2007-12-05 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Polypeptides derived from the hemopexin-like domain of metalloproteinase MMP-2
|
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
KR101526613B1
(ko)
|
2007-02-01 |
2015-06-26 |
악셀레론 파마 인코포레이티드 |
액티빈-ａｃｔｒⅱａ 길항제 및 유방암을 치료 또는 예방하기 위한 이들의 용도
|
|
US20090081659A1
(en)
|
2007-03-07 |
2009-03-26 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
EP1975184A3
(en)
|
2007-03-26 |
2008-11-26 |
Cell Signaling Technology, Inc. |
Serine or threonine phosphorylation sites
|
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
EP1983002A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
EP2207562B1
(en)
|
2007-09-18 |
2017-05-31 |
Acceleron Pharma, Inc. |
Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
|
|
US20090203043A1
(en)
|
2007-11-21 |
2009-08-13 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
|
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
WO2012047966A2
(en)
*
|
2010-10-07 |
2012-04-12 |
Akebia Therapeutics Inc. |
Compositions and methods for treating ocular edema, neovascularization and related diseases
|
|
US9018352B2
(en)
|
2009-11-10 |
2015-04-28 |
Allegro Pharmaceuticals, Inc. |
Peptide compositions and therapeutic uses thereof
|
|
US11673914B2
(en)
|
2009-11-10 |
2023-06-13 |
Allegro Pharmaceuticals, LLC |
Peptide therapies for reduction of macular thickening
|
|
RU2429836C1
(ru)
*
|
2010-04-01 |
2011-09-27 |
Максуд Мухамеджанович Расулов |
СРЕДСТВО, СТИМУЛИРУЮЩЕЕ ЭКСПРЕССИЮ МАТРИЧНОЙ РНК ТРИПТОФАНИЛ-тРНК-СИНТЕТАЗЫ
|
|
EP3243530B1
(en)
|
2011-05-09 |
2020-07-08 |
Allegro Pharmaceuticals, Inc. |
Integrin receptor antagonists and their use
|
|
EP2830663B1
(en)
|
2012-03-30 |
2019-02-06 |
Sorrento Therapeutics Inc. |
Fully human antibodies that bind to vegfr2
|
|
EP3515495A4
(en)
|
2016-09-26 |
2020-08-26 |
Ensemble Group Holdings |
CANCER ASSESSMENT AND TREATMENT PROCEDURES IN SUBJECTS WITH DYSREGULATED LYMPHATIC SYSTEMS
|
|
BR112019020451A2
(pt)
*
|
2017-03-31 |
2020-04-28 |
Univ California |
composições e métodos para se direcionar e matar células-tronco positivas de câncer ?lfa-v beta-3 positiva (cscs) e tratamento de cânceres resistentes ao medicamento
|
|
CN113663929A
(zh)
*
|
2021-09-24 |
2021-11-19 |
深圳市广利达精密机械有限公司 |
一种自动化机械加工零件自动加工分拣设备及其方法
|